Heart

Papers
(The H4-Index of Heart is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people274
Cardiovascular manifestations and treatment considerations in COVID-19263
Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis185
COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?152
Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19148
Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis142
Place and causes of acute cardiovascular mortality during the COVID-19 pandemic138
Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis116
Prevalence, incidence and survival of heart failure: a systematic review90
Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure89
Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China89
Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UK87
Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management78
Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction77
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-1976
Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis75
Excess of cardiovascular deaths during the COVID-19 pandemic in Brazilian capital cities74
Diagnosis, management and therapeutic strategies for congenital long QT syndrome70
Atrial fibrillation and the prothrombotic state: revisiting Virchow’s triad in 202066
Multimodality imaging assessment of mitral annular disjunction in mitral valve prolapse61
Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank60
Trends of global burden of atrial fibrillation/flutter from Global Burden of Disease Study 201754
Recent advances in percutaneous coronary intervention54
Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis54
Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges53
Arrhythmogenic left ventricular cardiomyopathy53
Global longitudinal strain: clinical use and prognostic implications in contemporary practice48
Differentiation between athlete’s heart and dilated cardiomyopathy in athletic individuals47
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry47
Community prevalence, mechanisms and outcome of mitral or tricuspid regurgitation46
Adult congenital heart disease and the COVID-19 pandemic46
Lung ultrasound-guided therapy reduces acute decompensation events in chronic heart failure45
Pregnancy in congenital heart disease: risk prediction and counselling44
Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis43
Maternal cardiovascular risk after hypertensive disorder of pregnancy42
Longitudinal associations between loneliness, social isolation and cardiovascular events41
Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction in China40
Cardiotoxicities of novel cancer immunotherapies40
Limit of detection of troponin discharge strategy versus usual care: randomised controlled trial39
Systematic review of current natural language processing methods and applications in cardiology39
0.029646158218384